Learn More
Genscript Corporation EGFRVIIIBiotin HisAvi Hum
Supplier: Genscript Corporation Z03941100
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors often as a consequence of gene amplification Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements with the most common extracellular domain mutation being EGFRvIII This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.